Hackensack University Medical Center is pleased to offer the new renal denervation (RDN) procedure for certain patients with high blood pressure.
New Cleveland Clinic research shows that consuming foods with erythritol, a popular artificial sweetener, increases risk of cardiovascular events such as heart attack and stroke. The findings, from a new intervention study in healthy volunteers, show erythritol made platelets (a type of blood cell) more active, which can raise the risk of blood clots.
Researchers from the University of Arkansas for Medical Sciences (UAMS) have discovered that an FDA-approved cholesterol drug holds the potential to disrupt the progression of Alzheimer's disease and other forms of dementia.
Scientists at Sanford Burnham Prebys and Salk Institute for Biological Studies have uncovered a new role for a protein known for its role in the brain helping control feelings of hunger or satiety, as well as in the liver to aid the body in maintaining a balance of energy during fasting. The new study shows that this protein also supports the maintenance of heart structure and function, but when it is overactive it causes thickening of the heart muscle, which is associated with heart disease.
A new small study led by Johns Hopkins Medicine researchers and published July 25th in the journal Nature Cardiovascular Research has revealed the impact of obesity on muscle structure in patients having a form of heart failure called heart failure with a preserved ejection fraction (HFpEF).
The Cedars-Sinai Accelerator program will greet its 10th accelerator class, featuring 10 innovative health-tech startup companies from the United States and around the globe.
By itself, AFib isn’t life-threatening, but it can lead to life-threatening consequences. A Penn State Health expert discusses why that flutter in your chest is important and new treatments that are available.
Scientists from the Immanuel Kant Baltic Federal University stated that the biological activity of extracts of four plants that growing in the Kaliningrad region is provided by phenolic compounds — aromatic alcohols. These substances provide antioxidant and antimicrobic properties to Aesculus hippocastanum, Melilotus officinalis, Eryngium maritimum, and Hedysarum neglectum.
Cardiologists in Mayo Clinic's Heart Rhythm Clinic are using a new innovative energy source to safely and successfully treat a common type of heart arrhythmia. The therapy, called pulsed field ablation (PFA), has received Food and Drug Administration (FDA) approval and represents a significant milestone in treating atrial fibrillation (AFib).
Wearables measure several aspects of health, and heart rate variability might be one of those. It may be surprising when your device informs you that your heart rate variability is high or low, but what does it mean? Elijah Behr, M.D., a cardiologist at Mayo Clinic Healthcare in London, explains heart rate variability and how it factors into health.
If current guidelines for cholesterol and high blood pressure treatment remain unchanged, a newly unveiled heart risk calculator would render 16 million people ineligible for preventive therapy.
An analysis of blood samples from thousands of study participants, led by researchers at UT Southwestern Medical Center, revealed 18 proteins associated with both heart failure and frailty, conditions that commonly develop in late life.
Two recent grants from the National Institutes of Health (NIH) and American Heart Association are helping fund research of a novel vascular stent being developed at The Ohio State University Wexner Medical Center. The multi-use retrievable stent has the potential to save lives by improving vascular surgery and drug delivery as well as expanding organ donation.
Maintaining good oral health is crucial, not only for a radiant smile, but also a healthy heart, according to a new Case Western Reserve University study. Researchers at Case Western Reserve University School of Dental Medicine found “significant” evidence linking tooth loss to an increased risk of death from cardiovascular disease (CVD).
Utah-based Second Heart Assist Inc., announced today the successful completion of the company's first Central American case to evaluate the performance of its Whisper™ percutaneous mechanical circulatory device, designed to improve both cardiac function and renal perfusion in patients hospitalized with acute decompensated heart failure (ADHF). Second Heart Assist has already successfully performed FIH studies in Panama (South America) and other OUS countries for multiple indications.
How a person’s immune system responds to a protein called LL-37 may increase risk for developing acute coronary syndrome, but the response may also serve as a potential target for future treatments.
Personalized text messages effectively promoted increased physical activity for patients after significant heart events — such as a heart attack or surgery — but those effects later diminished.
Loyola University Medical Center (LUMC) has earned the American Heart Association’s Get With The Guidelines® - Stroke Gold Plus quality achievement award for its commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines, ultimately leading to more lives saved and reduced disability.
There’s still much to learn about how doxorubicin, a 50-year-old chemotherapy drug, causes its most concerning side effects. While responsible for saving many lives, this treatment sometimes causes cardiac damage that stiffens the heart and puts a subset of patients at risk for future heart failure. To better understand and potentially control such complications, Tufts University School of Medicine and Tufts Graduate School of Biomedical Sciences researchers have isolated the immune cells that become overactive when patients take doxorubicin.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right